Condition
Bipolar Disorder Type 1
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06373016Not ApplicableRecruiting
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
NCT05705063Not ApplicableUnknown
Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar Illness
NCT05501626Not ApplicableUnknownPrimary
Evaluation of Theta-burst Stimulation Efficacy, Safety and Tolerability in Major Depressive Episodes of Bipolar I Disorder
Showing all 3 trials